MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effect of differences in stomach and small intestine pH on response to levodopa in patients with Parkinson’s Disease.

M. Arena, B. Brumbach, S. Diamond, K. Block, J. Nutt, R. Pfeiffer, D. Safarpour (Portland, USA)

Meeting: 2023 International Congress

Abstract Number: 1367

Keywords: Levodopa(L-dopa)

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: To examine levels of stomach and small intestine (SI) pH in relation to variable clinical responses to doses of levodopa in Parkinson’s disease (PD) patients.

Background: A relationship between levodopa response and pH throughout the stomach and SI in patients with PD was explored using wireless motility capsules. Establishing a connection will better elucidate the impact of pH on levodopa absorption.

Method: The study included 10 PD patients with typical response to levodopa (time to “ON” within 1 hour) and 10 erratic responders (sudden “ON”/”OFFs”, delayed time to “ON”, response failure). The capsules captured continuous stomach and SI motility and pH data. Dose response was assessed by finger tapping scores and patient reporting every 30 minutes for 3 hours.

Results: Average mean gastric pH was 1.85 for typical responders and 1.77 for erratic responders. Most typical responders had a median stomach pH between 0.5 and 1.5; most erratic responders were between 0.5 and 2.5. Percent of time spent between a gastric pH range of 1.5-3.5 was calculated. Typical responders had an average 17% of time within that range, 63% time below 1.5 and 20% above 3.5. Erratic responders averaged 31% of time within range, 56% time below 1.5, and 13% above 3.5. The pH profile of the SI appeared to be similar between the 2 groups in averages, medians and proportion of time in ideal range. Of typical responders, 9 reported being ON within 1 hour of their first levodopa dose. Only 6 erratic responders reported being ON in 1 hour. At 180 minutes, 8 of the erratic responders reported being ON, but only 2 typical responders reported still feeling ON. Finger tapping scores improved for 90% of typical responders in 1 hour compared to only 50% of erratic responders.

Conclusion: Erratic responders reported more delayed time to ON than typical responders and showed less clinical improvement within 1 hour. In the stomach, erratic responders showed more spread of pH values. Typical responders averaged more time spent at gastric pH levels below 1.5. Further exploration of pH differences throughout the stomach and SI is needed to define an ideal range of pH for levodopa absorption. This could provide crucial information for improving efficacy of doses and clinical outcomes for PD patients1.

References: 1. Rivera-Calimlim L, Dujovne CA, Morgan JP, Lasagna L, Bianchine JR (1970) L-dopa treatment failure: explanation and correction. Br Med J 4:93–94.

To cite this abstract in AMA style:

M. Arena, B. Brumbach, S. Diamond, K. Block, J. Nutt, R. Pfeiffer, D. Safarpour. Effect of differences in stomach and small intestine pH on response to levodopa in patients with Parkinson’s Disease. [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/effect-of-differences-in-stomach-and-small-intestine-ph-on-response-to-levodopa-in-patients-with-parkinsons-disease/. Accessed September 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effect-of-differences-in-stomach-and-small-intestine-ph-on-response-to-levodopa-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Carpal Tunnel Syndrome in Patients with Tremor
  • #23972 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • #22892 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley